Literature DB >> 9085223

Analysis of the protease and adhesin domains of the PrpRI of Porphyromonas gingivalis.

M A Curtis1.   

Abstract

The production of extracellular proteolytic enzymes is a widely used strategy by human parasites including bacteria, protozoa and helminths in order to ensure survival in the colonized host. The potential benefits to the organism arise through modifications to the external environment of the cell and include the release of essential nutrients, the disablement/deregulation of the host defences and the exposure of previously shielded substrata as new sites for colonization. Damage to the host may arise through direct proteolysis of structural proteins, deregulation of the inflammatory response or the compromising of the local host defences below the threshold necessary for effective defence. In order to examine these interactions and how they may be regulated in the periodontal diseases, we are examining the properties of proteases of the oral anaerobe Porphyromonas gingivalis with specificity for arginyl peptide bonds (ArgI, ArgIA and ArgIB): a family of enzymes which has been shown to exert effects on a variety of host proteins with roles in the control of inflammation and tissue homeostasis. Analysis of the gene for ArgI (protease polyprotein for ArgI-prpRI) together with structural and immunochemical studies of these 3 interrelated forms indicates that they may be regarded as critical determinants in multiple aspects of the life cycle of the organism via both proteolysis and binding processes. Together with the highly conserved nature of the gene, the data suggest that the PrpRI of P. gingivalis is an essential colonization determinant which may play an important role in the periodontal disease process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085223     DOI: 10.1111/j.1600-0765.1997.tb01394.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  8 in total

1.  Does the importance of the C-terminal residues in the maturation of RgpB from Porphyromonas gingivalis reveal a novel mechanism for protein export in a subgroup of Gram-Negative bacteria?

Authors:  Ky-Anh Nguyen; James Travis; Jan Potempa
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

2.  Construction of a functional single-chain variable fragment antibody against hemagglutinin from Porphyromonas gingivalis.

Authors:  Y Shibata; K Kurihara; H Takiguchi; Y Abiko
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Effect of temperature on growth, hemagglutination, and protease activity of Porphyromonas gingivalis.

Authors:  R S Percival; P D Marsh; D A Devine; M Rangarajan; J Aduse-Opoku; P Shepherd; M A Curtis
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Targeted disruption of fibronectin-integrin interactions in human gingival fibroblasts by the RI protease of Porphyromonas gingivalis W50.

Authors:  M A Scragg; S J Cannon; M Rangarajan; D M Williams; M A Curtis
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

Authors:  M A Curtis; A Thickett; J M Slaney; M Rangarajan; J Aduse-Opoku; P Shepherd; N Paramonov; E F Hounsell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Maturation of the arginine-specific proteases of Porphyromonas gingivalis W50 is dependent on a functional prR2 protease gene.

Authors:  J Aduse-Opoku; M Rangarajan; K A Young; M A Curtis
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 7.  Metal uptake in host-pathogen interactions: role of iron in Porphyromonas gingivalis interactions with host organisms.

Authors:  Janina P Lewis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

8.  Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells.

Authors:  Margaret A Scragg; Asil Alsam; Minnie Rangarajan; Jennifer M Slaney; Philip Shepherd; David M Williams; Michael A Curtis
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.